06
04
2020
Congratualtions to Medicilon’s partner, Bio-Thera, on obtaining NMPA’s approval of clinical trials of BAT1308.
05
26
2020
On May 22, 2020, Kintor Pharmaceutical Limited (stock code: 9939. HK) was officially listed on the Hong Kong Stock Exchange. We medicilon extend the congratulations and best wishes.
01
13
2020
Medicilon was awarded “2019 Excellent Listed Enterprise” for its remarkable innovation and advances in the year 2019, at ZJ Science City Annual Event in Jan. 10th, 2020.
05
15
2018
HH185 was synthesized by Medicilon and completed some preclinical pharmacokinetic research and safety evaluation.
09
26
2017
The researchers discovered that a small genetic mutation in the frogs prevents the toxin from acting on the frogs’ own receptors, making them resistant to its lethal effects.
